Efficacy and Safety of LongShengZhi Capsule on Functional Recovery After Acute Ischaemic Stroke (LONGAN)
Status:
Not yet recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine if LongShengZhi Capsule is effective and safe in
patients with ischemic stroke in comparison to placebo. This trial is a prospective,
multicenter, randomized, placebo-controlled, double-blinded, parallel-group, superiority
trial.